tenk.fyi

Surrozen, Inc./DE

SRZNNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$3.5M

67.4% YoY

Net Income

-$242.0M

280.8% YoY

EPS

$-32.37

49.4% YoY

Cash

$89.2M

158.2% YoY

FY 2025 · As of 2025-12-31